27635325|t|Anxiolytic effects of fluoxetine and nicotine exposure on exploratory behavior in zebrafish
27635325|a|Zebrafish (Danio rerio) have emerged as a popular model for studying the pharmacology and behavior of anxiety. While there have been numerous studies documenting the anxiolytic and anxiogenic effects of common drugs in zebrafish, many do not report or test for behavioral differences between the sexes. Previous studies have indicated that males and females differ in their baseline level of anxiety. In this study, we test for a sex interaction with fluoxetine and nicotine. We exposed fish to system water (control), 10 mg/L fluoxetine, or 1 mg/L nicotine for three minutes prior to being subjected to four minutes in an open-field drop test. Video recordings were tracked using ProAnalyst. Fish from both drug treatments reduced swimming speed, increased vertical position, and increased use of the top half of the open field when compared with the control, though fluoxetine had a larger effect on depth related behaviors while nicotine mostly affected swimming speed. A significant sex effect was observed where females swam at a slower and more constant speed than males, however neither drug produced a sex - dependent response.
27635325	0	18	Anxiolytic effects	T039	C3179404
27635325	22	32	fluoxetine	T109,T121	C0016365
27635325	37	45	nicotine	T109,T131	C0028040
27635325	58	78	exploratory behavior	T055	C0015328
27635325	82	91	zebrafish	T013	C0043457
27635325	92	101	Zebrafish	T013	C0043457
27635325	103	114	Danio rerio	T013	C0043457
27635325	142	147	model	T075	C0026339
27635325	152	160	studying	T062	C2603343
27635325	165	177	pharmacology	T169	C0205464
27635325	182	190	behavior	T053	C0004927
27635325	194	201	anxiety	T033	C0003467
27635325	234	241	studies	T062	C2603343
27635325	258	268	anxiolytic	T039	C3179404
27635325	273	291	anxiogenic effects	T048	C1456290
27635325	302	307	drugs	T121	C0013227
27635325	311	320	zebrafish	T013	C0043457
27635325	334	340	report	T170	C0684224
27635325	344	348	test	T169	C0039593
27635325	353	363	behavioral	T053	C0004927
27635325	364	375	differences	T080	C1705242
27635325	388	393	sexes	T032	C0079399
27635325	404	411	studies	T062	C2603343
27635325	432	437	males	T032	C0086582
27635325	442	449	females	T032	C0086287
27635325	466	474	baseline	T081	C1442488
27635325	475	480	level	T080	C0441889
27635325	484	491	anxiety	T033	C0003467
27635325	501	506	study	T062	C2603343
27635325	522	525	sex	T032	C0079399
27635325	526	537	interaction	T169	C1704675
27635325	543	553	fluoxetine	T109,T121	C0016365
27635325	558	566	nicotine	T109,T131	C0028040
27635325	579	583	fish	T013	C0043457
27635325	587	599	system water	T121,T197	C0043047
27635325	601	608	control	T096	C0009932
27635325	619	629	fluoxetine	T109,T121	C0016365
27635325	641	649	nicotine	T109,T131	C0028040
27635325	660	667	minutes	T079	C0439232
27635325	701	708	minutes	T079	C0439232
27635325	715	735	open-field drop test	T059	C0022885
27635325	737	753	Video recordings	T073	C0042650
27635325	773	783	ProAnalyst	T073,T170	C0037585
27635325	785	789	Fish	T013	C0043457
27635325	800	804	drug	T121	C0013227
27635325	805	815	treatments	T169	C1522326
27635325	824	832	swimming	T055	C3549255
27635325	833	838	speed	T081	C0678536
27635325	840	849	increased	T081	C0205217
27635325	850	867	vertical position	T082	C0444402
27635325	894	920	top half of the open field	T082	C1254362
27635325	926	934	compared	T052	C1707455
27635325	944	951	control	T096	C0009932
27635325	960	970	fluoxetine	T109,T121	C0016365
27635325	994	1017	depth related behaviors	T055	C3549255
27635325	1024	1032	nicotine	T109,T131	C0028040
27635325	1049	1057	swimming	T055	C3549255
27635325	1058	1063	speed	T081	C0678536
27635325	1079	1082	sex	T032	C0079399
27635325	1083	1089	effect	T080	C1280500
27635325	1109	1116	females	T032	C0086287
27635325	1117	1121	swam	T055	C3549255
27635325	1143	1151	constant	T080	C1948059
27635325	1152	1157	speed	T081	C0678536
27635325	1163	1168	males	T032	C0086582
27635325	1186	1190	drug	T121	C0013227
27635325	1202	1205	sex	T032	C0079399
27635325	1208	1217	dependent	T169	C3244310
27635325	1218	1226	response	T032	C0871261